KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Assets (2016 - 2025)

Sarepta Therapeutics has reported Return on Assets over the past 15 years, most recently at 0.02% for Q4 2025.

  • Quarterly results put Return on Assets at 0.02% for Q4 2025, down 8.0% from a year ago — trailing twelve months through Dec 2025 was 0.02% (down 8.0% YoY), and the annual figure for FY2025 was 0.02%, down 9.0%.
  • Return on Assets for Q4 2025 was 0.02% at Sarepta Therapeutics, up from 0.08% in the prior quarter.
  • Over the last five years, Return on Assets for SRPT hit a ceiling of 0.11% in Q3 2024 and a floor of 0.28% in Q1 2023.
  • Median Return on Assets over the past 5 years was 0.07% (2025), compared with a mean of 0.07%.
  • Biggest five-year swings in Return on Assets: decreased -28bps in 2023 and later surged 37bps in 2024.
  • Sarepta Therapeutics' Return on Assets stood at 0.02% in 2021, then plummeted by -781bps to 0.14% in 2022, then surged by 44bps to 0.08% in 2023, then surged by 178bps to 0.06% in 2024, then tumbled by -137bps to 0.02% in 2025.
  • The last three reported values for Return on Assets were 0.02% (Q4 2025), 0.08% (Q3 2025), and 0.02% (Q2 2025) per Business Quant data.